NJ Spotlight News | Clip | Johnson & Johnson vaccine on track for February FDA approval

New Brunswick-based Johnson & Johnson is on track to seek approval for its one-dose COVID-19 vaccine early next month. The vaccine is currently in late-stage trials, with important safety data coming by the end of the month. Johnson & Johnson has set a goal of providing 1 billion doses this year.

0:02:35 | AIRED: 1/11/2021 |

EMBED CODE

NJ Spotlight News

Johnson & Johnson vaccine on track for February FDA approval

<iframe width="512" height="376" src="https://player.pbs.org/viralplayer/3050798759" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" seamless allowfullscreen></iframe>COPY TO CLIPBOARD